1. Home
  2. TEM vs BIO Comparison

TEM vs BIO Comparison

Compare TEM & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEM
  • BIO
  • Stock Information
  • Founded
  • TEM 2015
  • BIO 1952
  • Country
  • TEM United States
  • BIO United States
  • Employees
  • TEM N/A
  • BIO N/A
  • Industry
  • TEM
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • TEM
  • BIO Industrials
  • Exchange
  • TEM NYSE
  • BIO Nasdaq
  • Market Cap
  • TEM 6.3B
  • BIO 9.1B
  • IPO Year
  • TEM 2024
  • BIO N/A
  • Fundamental
  • Price
  • TEM $31.83
  • BIO $342.01
  • Analyst Decision
  • TEM Buy
  • BIO Strong Buy
  • Analyst Count
  • TEM 11
  • BIO 4
  • Target Price
  • TEM $57.20
  • BIO $414.00
  • AVG Volume (30 Days)
  • TEM 4.0M
  • BIO 158.1K
  • Earning Date
  • TEM 02-17-2025
  • BIO 02-13-2025
  • Dividend Yield
  • TEM N/A
  • BIO N/A
  • EPS Growth
  • TEM N/A
  • BIO N/A
  • EPS
  • TEM N/A
  • BIO N/A
  • Revenue
  • TEM $640,442,000.00
  • BIO $2,580,209,000.00
  • Revenue This Year
  • TEM $32.70
  • BIO N/A
  • Revenue Next Year
  • TEM $38.77
  • BIO $2.92
  • P/E Ratio
  • TEM N/A
  • BIO N/A
  • Revenue Growth
  • TEM 32.13
  • BIO N/A
  • 52 Week Low
  • TEM $22.89
  • BIO $262.12
  • 52 Week High
  • TEM $79.49
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • TEM N/A
  • BIO 53.78
  • Support Level
  • TEM N/A
  • BIO $335.42
  • Resistance Level
  • TEM N/A
  • BIO $351.96
  • Average True Range (ATR)
  • TEM 0.00
  • BIO 9.09
  • MACD
  • TEM 0.00
  • BIO 2.06
  • Stochastic Oscillator
  • TEM 0.00
  • BIO 59.23

About TEM TEMPUS AI INC

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: